PetMed Express Inc (PETS, Financial) is set to release its Q2 2025 earnings on Nov 6, 2024. The consensus estimate for Q2 2025 revenue is $66.00 million, and the earnings are expected to come in at -$0.05 per share. The full year 2025's revenue is expected to be $266.03 million and the earnings are expected to be $0.09 per share. More detailed estimate data can be found on the Forecast page.
PetMed Express Inc (PETS, Financial) Estimates Trends
Over the past 90 days, revenue estimates for PetMed Express Inc (PETS) for the full year 2025 have declined from $281.25 million to $266.03 million and for 2026 from $293.38 million to $274.73 million. Earnings estimates for the full year 2025 have increased from -$0.16 per share to $0.09 per share, while for 2026, they have declined from -$0.07 per share to -$0.18 per share.
PetMed Express Inc (PETS, Financial) Reported History
In the previous quarter of June 30, 2024, PetMed Express Inc's (PETS) actual revenue was $67.95 million, which missed analysts' revenue expectations of $75.00 million by -9.4%. PetMed Express Inc's (PETS) actual earnings were $0.18 per share, which beat analysts' earnings expectations of -$0.06 per share by 400%. After releasing the results, PetMed Express Inc (PETS) was down by -14.36% in one day.
PetMed Express Inc (PETS, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 2 analysts, the average target price for PetMed Express Inc (PETS) is $3.50 with a high estimate of $3.50 and a low estimate of $3.50. The average target implies a downside of -17.06% from the current price of $4.22.
Based on GuruFocus estimates, the estimated GF Value for PetMed Express Inc (PETS, Financial) in one year is $18.62, suggesting an upside of 341.23% from the current price of $4.22.
Based on the consensus recommendation from 2 brokerage firms, PetMed Express Inc's (PETS, Financial) average brokerage recommendation is currently 3.5, indicating a "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
